(Q48593851)

13 February 2018

title

Clinical application of a dendritic cell vaccine raised against heat-shocked glioblastoma. (English)

1 reference

13 February 2018

author name string

X Jie

1

1 reference

13 February 2018

L Hua

2

1 reference

13 February 2018

W Jiang

3

1 reference

13 February 2018

F Feng

4

1 reference

13 February 2018

G Feng

5

1 reference

13 February 2018

Z Hua

6

1 reference

13 February 2018

publication date

1 January 2012

1 reference

13 February 2018

Cell Biochemistry and Biophysics

published in

1 reference

13 February 2018

volume

62

1 reference

13 February 2018

issue

1

1 reference

13 February 2018

page(s)

91-99

1 reference

13 February 2018

https://scigraph.springernature.com/pub.10.1007/s12013-011-9265-6

exact match

0 references

cites work

Preliminary results of active specific immunization with modified tumor cell vaccine in glioblastoma multiforme.

1 reference

https://api.crossref.org/works/10.1007%2FS12013-011-9265-6

Treatment of intracranial gliomas with bone marrow-derived dendritic cells pulsed with tumor antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-011-9265-6

Results of a phase 1 study utilizing monocyte-derived dendritic cells pulsed with tumor RNA in children and young adults with brain cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-011-9265-6

Dendritic cell vaccines to combat glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-011-9265-6

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-011-9265-6

Dendritic cell vaccination in glioblastoma patients induces systemic and intracranial T-cell responses modulated by the local central nervous system tumor microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-011-9265-6

Vaccination with tumor lysate-pulsed dendritic cells elicits antigen-specific, cytotoxic T-cells in patients with malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-011-9265-6

Postoperative adjuvant dendritic cell-based immunotherapy in patients with relapsed glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-011-9265-6

Clinical evaluation of dendritic cell vaccination for patients with recurrent glioma: results of a clinical phase I/II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-011-9265-6

Immunotherapy for malignant glioma: current approaches and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-011-9265-6

Therapeutic dendritic cell vaccination of patients with metastatic renal cell carcinoma: a clinical phase 1/2 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-011-9265-6

Dendritic cell vaccination combined with CTLA4 blockade in patients with metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-011-9265-6

Immune responses in patients with metastatic renal cell carcinoma treated with dendritic cells pulsed with tumor lysate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-011-9265-6

Thymic CD8+ T Cell Production Strongly Influences Tumor Antigen Recognition and Age-Dependent Glioma Mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-011-9265-6

Sensitization of malignant glioma to chemotherapy through dendritic cell vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-011-9265-6

Toxicity and response criteria of the Eastern Cooperative Oncology Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12013-011-9265-6

10.1007/S12013-011-9265-6

21 January 2018

Identifiers

DOI

1 reference

13 February 2018

1 reference

13 February 2018